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K562 cellNeutrophils provide the ﬁrst line of defense against microbial invasion in part through production of reactive
oxygen species (ROS) which is mediated through activation of nicotinamide adenine dinucleotide phosphate
(NADPH) oxidase generating superoxide anion (O2−). The phagocyte oxidase (phox) has multiple protein
components that assemble on the plasmamembrane in stimulated neutrophils. We recently described a protein
in neutrophils, peroxiredoxin 6 (Prdx6), which has both peroxidase and phospholipase A2 (PLA2) activities and
enhances oxidase activity in an SDS-activated, cell-free system. The function of Prdx6 in phox activity is further
investigated. In reconstituted phox-competent K562 cells, siRNA-mediated suppression of Prdx6 resulted in
decreased NADPH oxidase activity in response to formyl-methionyl-leucyl-phenylalanine (fMLP) or phorbol
myristate acetate (PMA). In neutrophils stimulated with PMA, Prdx6 translocated to plasmamembrane as dem-
onstrated by Western blot and confocal microscopy. Translocation of Prdx6 in phox competent K562 cells re-
quired both p67phox and p47phox. In addition, plasma membrane from PMA-stimulated, oxidase competent
K562 cells with siRNA-mediated Prdx6 suppression contained less p47phox and p67phox compared to cells in
which Prdx6 was not decreased. Cell-free oxidase assays showed that recombinant Prdx6 did not alter the Km
for NADPH, but increased the Vmax for O2− production in a saturable, Prdx6 concentration-dependent manner.
Recombinant proteins with mutations in Prdx (C47S) and phospholipase (S32A) activity both enhanced cell-
free phox activity to the same extent aswild type protein. Prdx6 supports retention of the active oxidase complex
in stimulated plasma membrane, and results with mutant proteins imply that Prdx6 serves an additional bio-
chemical or structural role in supporting optimal NADPH oxidase activity.
© 2011 Elsevier B.V. All rights reserved.1. Introduction
Neutrophils provide the host with a ﬁrst line of defense against
microbial invasion. These cellsmigrate to the site of infection and ingest
microorganisms [1–5]. As the phagosome forms, fusion of speciﬁc andlalanine; H2O2, hydrogen per-
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l rights reserved.azurophilic granules releases contents of these organelles into the
phagolysosome; and activation of the respiratory burst generates
superoxide anion (O2−) [2] and other reactive oxygen species (ROS)
[6,7]. The focus of ROS dependent and independent antimicrobial sys-
tems on the ingested microbe leads to its death and dissolution [6,7].
The neutrophil respiratory burst involves activation of the NADPH
oxidase composed of multiple components including p22phox and
gp91phox, forming the ﬂavocytochrome b558, and regulator proteins
designated as p47phox, p67phox and p40phox, and Rac2 [6,7]. In
unstimulated neutrophils, the latter four proteins reside in the cytosol
while ﬂavocytochrome b558 is associated with plasma membrane and
speciﬁc granules [8,9]. With activation, cytosolic phox components
translocate to the plasma membrane and NADPH oxidase activity is
expressed reducing oxygen to O2− [8–10]. Chronic granulomatous disease
(CGD), an inherited disorder of bactericidal activity, illustrates the im-
portance of the phagocyte NADPH oxidase activity and ROS in host de-
fense [6]. A deﬁciency of any one of these essential phox proteins leads
to an inactive oxidase and impaired ROS production; afﬂicted patients
suffer from recurrent, life-threatening infections with catalase positive
microbes and inﬂammatory diseases.
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H2O2 with concomitant oxidation of active site cysteine residues
[11]. These proteins may serve to protect against the damaging effects
of ROS or in a signaling role by controlling levels of H2O2 [11]. We re-
cently demonstrated the presence of Prdx6 in neutrophils [12] as a
29 kDa protein (originally designated p29) with amino acid sequence
identical to Prdx6 and with Prdx enzyme activity and showed that it
binds to p67phox, exhibits a phospholipase A2 (PLA2) activity, and
enhances NADPH oxidase activity [12]. In the following studies we
investigate further the role of Prdx6 in regulation of NADPH oxidase
activity and show that its translocation to the membrane in stimulated
cells is linked with assembly and activation of the oxidase.2. Materials and methods
2.1. Materials
SDS, cytochrome c, PIPES and TRIS buffers, NADPH, imidazole,
Dextran, Ficoll-Hypaque, EGTA, sucrose, glycine, ethanolamine, PMA,
fMLP, leupeptin, DFP, phenylmethanesulfonyl ﬂuoride (PMSF), horse-
radish peroxidase, o-phenylenediamine, DTT, and Tween 20 were
purchased from Sigma (St. Louis, MO). Ficoll-Hypaque, HRP-labeled
anti-rabbit IgG and enhanced chemiluminescence (ECL) reagents
were obtained from GE Healthcare (Piscataway, NJ). Donkey anti-
goat IgG was from Rockland Immunochemicals (Gilbertsville, PA).
Nickel afﬁnity resin, RPMI, Cy5 and Alexa 488 (FITC), and labeling
kits were from Invitrogen (Carlsbad, CA). Heparin was purchased
from APP Pharmaceuticals (Schaumburg, IL); Nunc plates (96 well),
BCA protein quantitation reagents, and Dithiobis [succinimidyl propio-
nate] (DSP)were fromThermo-Scientiﬁc (Rochester, NY); and acrylam-
ide and nitrocellulose from Biorad (Hercules, CA). Constitutively active
Rac1 was from Cytoskeleton (Denver, CO) and Diogenes from National
Diagnostics (Charlotte, NC). Antibodies for gp91phox, p22phox,
p40phox, p47phox, and p67phox were obtained as previously de-
scribed [8,12–15] and an antibody for the amino-terminal end of
p67phox was from Santa Cruz Biotechnology (Santa Cruz, CA). Anti-
bodies to actin, CD45 and FITC mouse anti-human IgG were obtained
from BD Immunocytometry (San Jose, CA). Cy5 rabbit anti-human IgG,
Cy3 goat anti-mouse IgG and Cy3 labeled goat anti-mouse antibody
were from Accurate (Westbury, NY). Krebs Ringers phosphate buffer
with dextrose (KRPD) and cavitation buffer were prepared as previous-
ly noted [12].2.2. Isolation of neutrophils and preparation of subcellular fractions
Heparinized (10 units/ml) peripheral blood was obtained from
healthy adult volunteers after signed consent which was approved by
the Combined Institutional Review Board at the University of Colorado
Denver. Neutrophilswere isolated by the standard technique of Dextran
sedimentation, Ficoll-Hypaque density gradient centrifugation and
hypotonic lysis of red cells [13,14]. Neutrophils were incubated with
buffer or PMA (1 μg/ml) for 5 min at 37 °C; and subcellular fractions
were isolated by sucrose density gradient centrifugation after disrup-
tion of the cells with nitrogen cavitation in the presence of DFP (1 mM),
leupeptin (1 μg/ml) and PMSF (0.2 mM) as previously described
[8,13–15].
For subcellular fractions from K562 cells, 108 cells/ml were sus-
pended in cavitation buffer and sonicated in a Branson sonicator
(Heat Systems Ultrasonics, Plainview, NY) with three, 15 s bursts
[16,17]. After centrifugation (250 g) to remove unbroken cells, puriﬁed
plasmamembranes and cytosol were collected on a sucrose gradient as
previously described [16,17]. Plasma membrane and other subcellular
fractions were immediately frozen at −70 °C. Protein concentration
was determined by BCA protein assay.2.3. Recombinant proteins
Using standardmolecular biology techniques, a previously described
[12] p29 (Prdx6) ORF with an N-terminal extension that included a
poly-His tag was moved to pBlueBacHis 2B (Invitrogen). Mutant ver-
sions of this plasmid with substitution of serine for cysteine at amino
acid 47 and an alanine for serine at amino acid 32 (numbering relative
to untagged protein) were produced using QuickChange Mutagenesis
(GE Healthcare) [13,18]. For all expression plasmids, the correct se-
quence was conﬁrmed by DNA sequencing. Recombinant human (rh)
Prdx6 (or rh-wt) and the two mutants (rh-C47S and rh-S32A) were
produced by expression in Sf-9 cells and puriﬁed by Ni2+ afﬁnity chro-
matography [12].
The peroxidase and PLA2 activity of rh-wt protein have been de-
scribed byus andothers [11,12,18–20]. The deletion of peroxidase activity
by mutating the cysteine at position 47 has been described [19,21,22].
We conﬁrmed this effect in our C47S mutant with a glutamine synthe-
tase protection assay [12]. The C47Smutant exhibited 8.6±6.4% protec-
tion compared to 85.4±4.9% protection by hr-wt (pb0.0001) two-
tailed t-test. The contribution of serine to the active catalytic site for
PLA2 enzymes is well deﬁned in the literature [23,24] and has been
demonstrated for Prdx6 [21,25].
2.4. Polyclonal Prdx6 and other antibodies
Puriﬁed rh-Prdx6 [12] (1 mg/ml) was used to raise a polyclonal
antibody in rabbits. The initial immunization was completed with
the recombinant protein in Freund's adjuvant, and was followed by
two subsequent immunizations. Pre-immune serum and serum after
the third injection were screened for antibody by an ELISA based
technique. rh-Prdx6 (180 μg) was added to wells of a microtiter
plate. Various dilutions of pre and post immune serum (50 μl) from
neat to 1/100,000 dilution were added to the wells, incubated at RT
for 1 h and washed three times with PBS-tween. HRP labeled anti-
rabbit IgG was added for an hour andwashed. OD at 490 nmwas mea-
sured after addition of o-phenylenediamine. High titered (1/20,000–1/
100,000) reactivity was detected in all post-immune sera (OD≥0.5)
compared to pre-immune serum (OD≤0.02). Anti-Prdx6, either as im-
mune serum or IgG fraction, puriﬁed by protein A afﬁnity chromatog-
raphy [15], reacted with all Prdx6 proteins as well as Prdx6 from cell
lysates or subcellular fractions in Western blots. Afﬁnity puriﬁed IgG
anti-Prdx6 labeled with Cy5 (Invitrogen kit) was used in confocal
experiments.
2.5. SDS activated cell-free system of oxidase activity
Production of O2− in a cell-free system of NADPH oxidase activity
was performed as previously described [8,12–14], but with further op-
timization to provide maximal oxidase activity as follows: 100 nM
p67phox, 100 nM p47phox, 32 nM constitutively active Rac1 plus or
minus varying amounts of rh-Prdx6 or buffer were combined in buffer
to 100 μl. After 10 min incubation at RT, 1 μg of plasma membrane
from unstimulated neutrophils and SDS (112.5 μM) were introduced.
After 3 min, NADPH (varying concentrations in 15 μl) was added to
give a total assay volume of 150 μl and the initial rate of O2− production
was determined as SOD-inhibitable cytochrome c reduction in an ELISA
reader at 550 nMas previously reported [12–14]. In one series of exper-
iments, rh-Prdx6 (0, 0.27, 0.55, 1.10, and 2.20 μM)was added to the re-
actionmixture andNADPH (0–200 μM) started the reaction. Initial rates
of O2− production were determined, the data ﬁt to the Michaelis–Men-
ten equation and kinetic parameters, Km (for NADPH) and Vmax, were
calculated using Prism software (GraphPad Software Inc., La Jolla, CA).
In a second set of experiments, a wider range of Prdx6 concentrations
were added to the cell-free system, 200 μM NADPH initiated the reac-
tion, and O2− production was determined. Changes in velocity from
the cell-free system alone were plotted against the concentration of
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S32A, were added to the standard assay mix and production of O2−
determined.
2.6. Confocal microscopy
For confocal microscopy studies, neutrophils were incubated with
buffer or PMA (1 μg/ml) for 5 min, ﬁxed to poly-L-lysine coated
coverslips with 3% paraformaldehyde, washed and incubated with
primary antibody to CD45 and a secondary Cy3 labeled rabbit anti-
IgG. The cells were then permeabilized with lysophosphatidylcholine
(100 μg/ml) for 5 min and incubated with anti-p67phox IgG labeled
with FITC and anti-p29 Prdx6 IgG labeled with Cy5 for 1 h at room
temperature. After washing, cells were imaged with a Leica DMRXA
digital ﬂuorescence microscope under a 100× lens, and the images
analyzed with an open-source image analysis tool, IMAJIN_COLOC de-
veloped in PERL (v. 5.8, build 806) using the PERL Magick libraries
(Image-Magick) [26]. Using a pixel-by-pixel analysis algorithm, this
program analyzes antigen expression and can measure all possible
combinations of co-localization for up to three distinct ﬂuorescent
probes. Background ﬂuorescence for each experiment was obtained
with cell preparations exposed to Cy3 labeled goat anti-mouse, Cy5
rabbit anti-human and FITC mouse anti-human IgG, processed as
noted above and subtracted from ﬂuorescence obtained with primary
antibodies using the analysis program. For all analyses, colors were
arbitrarily assigned, green for CD45, blue for p67phox, and red for
Prdx6.
2.7. K562 cells for siRNA knockdown of Prdx6 and for translocation
studies
NADPH oxidase-competent K562 cells were grown at 37 °C in 5%
CO2 with RPMI and 10% fetal calf serum [16,17,27]. These cells were
stably transduced with p47phox, p67phox, gp91phox (K+++) and
subsequently transfected with the fMLP receptor (FPR); this reconsti-
tuted line has sufﬁcient levels of endogenous p22phox, p40phox, and
Rac proteins to support NADPH oxidase activity in response to stimu-
lation by PMA or fMLP [17]. Small interfering RNA (siRNA) molecules
were designed to degrade the mRNA for Prdx6. The siRNAs were
uniquely targeted to hybridize 19-nucleotide sense-strand sequences
of Prdx6 [28–32] and were obtained commercially (Ambion, Austin,
TX and Qiagen, Valencia, CA). In preliminary studies with HEK293
cells, the three probes induced a robust knockdown of Prdx6 in com-
parison to a non-speciﬁc siRNA (Nsi) with no effect on actin protein
expression (data not shown). The sequences for the siRNAs were:
si1 (Qiagen), UUG GUG AAG ACU CCU UUC GGG; si2 (Ambion), GCA
AUC AAC UUA ACA UUC Ctc; si3 (Ambion), UGG GUA GAG GAU AGA
CAG Ctt; and Nsi (Qiagen), UUC UCC GAA CGU GUC ACG UdT dT. A
plasmid expressing GFP assessed transfection efﬁciency.
Transfections were conducted with Amaxa Nucleofector technology
(Lonza, Basel, Switzerland). Transgenic K562 cells (5×106, passageb12),
grown for 24 h, were resuspended in 100 μl Solution L. GFP plasmid
(provided by Lonza to assess transfection efﬁciency), si1, si2, si3, and
Nsi, were added at various concentrations (0.5, 1, 2, and 5 μM) to opti-
mize the knockdown and transfection completed with the T020 proto-
col. RPMIwith 10% (500 μl) FCSwas added and the cells were incubated
for 15 min at 37 °C. Cells were transferred to larger plates, brought up in
2 ml RPMI with 10% FCS, and cultured for various times before being
harvested for assays. Cell viability for all studies was determined by try-
pan blue exclusion and for all experiments was ≥90%.
For translocation studies, K+++ cells, the parent K562 cell line and
cell lines stably transduced with all other phox proteins except
p47phox (K67/91) or p67phox (K47/91) [16,17] grown as above
were exposed to PMA (1 μg/ml) or buffer for 5 min and subcellular
fractions prepared as noted above. Cell membranes were prepared
in si experiments after 48 h in culture with 1.5×107 cells at aconcentration of 108 cells/ml. Plasma membrane preparations were
evaluated for Prdx6 and other phox proteins by Western blotting.
2.8. Oxidase activity in reconstituted K562 cells
O2−productionwas determined by two techniques. Transgenic K+++
phox-competent cells (106/ml in KRPD) were stimulated with PMA
(200 ng/ml) in 150 μl volume and O2− production was measured as
SOD-inhibitable cytochrome c reduction [12–14]. Alternatively, 106
cells/ml in KRPD were added to 30 μl Diogenes and 1 μM fMLP to start
the reaction in an assay volume of 150 μl. Chemiluminescence was mea-
sured in a FB12 Luminometer (BertholdDetection Systems, Pforzheim,
Germany), as relative light units (RLUs). The maximum RLUs at 30 s
was used to measure the output of the respiratory burst; >95% of this
chemiluminescence was SOD-inhibitable indicating the reactivity was
O2−.
2.9. Cell lysates
Cell lysates were made with the addition of 10% Triton X-100 and
3 cycles of freeze/thaw (room temperature to −70 °C). Lysates were
stored at −70 °C.
2.10. Western blots
Western blots of subcellular fractions or protein preparations
were completed as previously described [8,12–15]. Protein fromplasma
membrane (2.5–25 μg, depending on cell type), recombinant protein
preparations (1 μg) or cell lysates (5–10 μg) were separated on 12.5%
SDS-PAGE, transferred to nitrocellulose and probed with the relevant
antibodies. For translocation studies in K562 cells, the antibody to the
amino-terminal end of p67phox was used. Analysis was completed
with the appropriate horseradish peroxidase labeled secondary anti-
body (donkey anti-goat IgG or goat anti-rabbit IgG), and ECL detection
system (GE Healthcare). The Image J program (v1.4) was used to quan-
titate proteins. For immunoprecipitation studies, plasma membrane
fraction from neutrophils stimulated with PMA were incubated with
goat, p67phox antiserum and protein G coated beads were added as
previously described [12]. Beads were extensively washed, treated
with SDS sample digestion buffer, the proteins separated on SDS PAGE
and transferred to nitrocellulose. Blots were probed with antibody to
p67phox and Prdx6 as noted above.
2.11. Statistical methods
Statistical evaluation of results was performed using unpaired t-test,
paired t-test and standard non-linear regression techniques (Prism soft-
ware, GraphPad Software Inc., La Jolla, CA).
3. Results
3.1. siRNA knockdown of Prdx6 in transgenic K562 cells
Our previous studies demonstrated enhancement of oxidase activity
by rh-Prdx6 (p29) in the cell-free system [12].We extended these ﬁnd-
ings with studies using intact cells. Because neutrophils are terminally
differentiated, short-lived and difﬁcult to transfect, we employed a
K562 cell model for our siRNA experiments. Production of genetically
modiﬁed cultured cells has provided powerful strategies to study the
activity of the oxidase [16,17,27,33]. The K+++ cells used are a clonally-
derived K562 cell line stably transduced with retroviral p47phox,
p67phox, gp91phox and were shown to express endogenous p22phox
and Rac [16,17,27]. They were subsequently transfected with the fMLP
receptor (FPR) [17]. Three siRNAmolecules were developed speciﬁcally
to degrade the mRNA of Prdx6 and decrease expression of this protein
in these cells. A non-silencing siRNA, (Nsi) which did not interfere
Fig. 1. siRNA knockdown of Prdx6 suppresses whole cell NADPH oxidase activity. (A) Rep-
resentative Western blot of lysates from phox-competent K562 (K+++) cells expressing
the fMLP receptor transfected with Prdx6-targeted si1, si2, or si3 or Nsi. Detection of
p67phox, p47phox, p40phox, p22phox and Actin all showed no difference between Nsi
and si molecules, whereas Prdx6 was decreased. (B) Quantitation of phox proteins, Actin
and Prdx6 in cells transfected with siRNA molecules were expressed as a % of Nsi control
(light gray, si1; black, si2; and dark gray, si3). Prdx6 was diminished to 26–43% of control
depending on the speciﬁc siRNA, whereas no signiﬁcant changes in phox proteins and
Actin were noted (85–120% of Nsi). These are results from 4 separate experiments and
are represented as mean±SEM. (C) O2− production in response to PMA detected by cyto-
chrome c reduction (nmol/min). Results presented as mean±SEM for 4 separate experi-
ments. (D) O2− production in response to fMLP. Insert shows a representative experiment
of chemiluminescence changes following addition of stimulus for cells pretreated with
siRNA molecules. Responses of cells treated with si1 (square), si2 (triangle), and si3 (di-
amond) were all decreased compared to Nsi control (circle). Larger graph summarizes 4
separate experiments measuring O2− production in response to fMLP by chemilumines-
cence (RLUs) at 30 s. Numbers represent mean±SEM.
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the active siRNA (si1, si2, and si3) and Nsi was achieved with Amaxa
Nucleofector technology (protocol T020 and solution L). Transfections
containing 5×106 K+++ cells and 2 μM si or Nsi, followed by 48 h in
culture gave maximal knockdown of Prdx6, with reversal of suppres-
sion occurring another 72 h later (data not shown) and were judged
≥90% efﬁcient based on separate experiments in which a GFP expres-
sing plasmid was transfected and cells monitored for ﬂuorescence.
Quantitation of Prdx6, phox proteins and actin was performed by
Western blotting after transfection of K+++ cells with si or Nsi mol-
ecules. A representative experiment is shown in Fig. 1A. Expression
of Prdx6 was reduced by si1, si2, and si3 as compared to Nsi. The
phox proteins including p67phox, p47phox, p40phox, or p22phox
were not decreased; and actin, used as a loading control, was also un-
affected. gp91phox was also not decreased (data not shown). Fig. 1B
summarizes quantiﬁcation of these proteins by Western blot densi-
tometry. Prdx6 was reduced to 26–43% depending on the speciﬁc si
used and the results were signiﬁcant (pb0.05, unpaired t-test). O2−
production was determined in the si treated K562 cells after stimula-
tion with PMA (200 ng/ml) as cytochrome c reduction or with fMLP
(1 μM) using chemiluminescence. Fig. 1C shows O2− production in re-
sponse to PMA. These data summarize results for four separate exper-
iments. The response to PMA in Prdx6-targeted, si-treated cells was
decreased to 50–65% of the Nsi control cells and this was signiﬁcant
(pb0.025, paired t-test). The suppressive effects of Prdx6 knockdown
on oxidase activation were greater when using fMLP as an agonist
(Fig. 1D), where O2− production for each Prdx6-targeted si was 16–
38% of Nsi control (pb0.025, paired t-test). The insert demonstrates
results of fMLP-stimulated oxidase kinetics from one experiment,
with the main graph summarizing results from all experiments.
These studies demonstrate the requirement of Prdx6 for optimal oxi-
dase activity in intact cells.
3.2. Translocation of Prdx6 with neutrophil activation
Stimulation of neutrophils results in translocation of p67phox,
p47phox, p40phox and Rac2 to the plasma membrane to bind to cy-
tochrome b558 (gp91phox and p22phox) to form an active oxidase
complex [8–10]. If Prdx6 binds to p67phox and enhances oxidase
activity, one would expect translocation of this protein as well. To
evaluate translocation, subcellular fractions from unstimulated and
PMA-stimulated neutrophils were prepared as described in Methods
(Section 2.2). Proteins from unstimulated and PMA-stimulated plas-
ma membrane were separated by SDS-PAGE, blotted to nitrocellulose
and Prdx6 was detected byWestern blotting. Representative blots are
shown in Fig. 2A. PMA stimulation of neutrophils results in a dramatic
increase in Prdx6 associated with the plasma membrane. Results for
p67phox and p47phox are included for comparison. In eight separate
preparations, densitometry of Western blots indicated that the PMA-
stimulated plasma membranes had a 1.5–8 fold increase in Prdx6
(pb0.010 by paired t-test) over simultaneously blotted plasma mem-
branes from unstimulated cells. In comparison, p67phox was 1.5–10
and p47phox 2.3–11 fold increased (both pb0.005 by paired t-test)
in PMA-stimulated plasma membranes. When plasma membrane
from PMA stimulated neutrophils was immunoprecipitated with anti-
body against p67phox, Prdx6 was pulled down with p67phox (Fig. 2B)
providing further evidence of their interaction.
In a second approach, confocal microscopy was performed with
unstimulated and PMA-stimulated cells imaged for Prdx6, p67phox
and a membrane/cell surface marker CD45 with ﬂuorescently labeled
antibodies and analyzed using IMAJIN-COLOC software [26]. Fig. 3A
shows an unstimulated neutrophil with images for CD45 (green),
p67phox (blue), and Prdx6 (red) separately; a merge of all three;
and a panel demonstrating only pixels with all three colors (white,
RGB colocalization). In unstimulated cells, Prdx6 and p67phox were
localized together in the cytosol (purple). Although small amounts
Fig. 2. (A) Translocation of Prdx6 to plasma membrane from unstimulated and PMA
stimulated neutrophils. Subcellular fractions were prepared after incubation with buffer
or PMA as noted in Materials and methods. Plasma membrane proteins (25 μg) were
separated by SDS-PAGE and Western blotted to detect p67phox, Prdx6 and p47phox.
Membranes from PMA-stimulated cells show an increase in phox proteins and Prdx6.
This is representative of 4 experiments from separate subcellular fraction preparations.
(B) Immunoprecipitation of plasma membrane from PMA stimulated neutrophils with
antibody for p67phox. Representative blot of two separate experiments shows Prdx6
co-immunoprecipitating with p67phox.
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RGB colocalization) consistent with the Western blots, Prdx6 and
p67phox remained largely distinct from CD45. In PMA-stimulated
cells, more Prdx6 and p67phox became associated with CD45 and the
plasma membrane (Fig. 3B, merged and RGB colocalization) consistent
with co-translocation of both proteins to the plasma membrane after
stimulation of the neutrophil. These images are representative of 28
unstimulated cells and 51 stimulated cells analyzed over six separate
preparations.
Further analysis was completed using IMAJIN_COLOC software
[27]. The confocal microscopy images of individual cells were evaluated
for the number of p67phox, Prdx6 and CD45 pixels within them. The
ﬁrst analysis determined colocalization of two ﬂuors, CD45 and Prdx6
or p67phox (Fig. 3C); pixels containing CD45 and Prdx6 expressed as
a percent of total Prdx6 pixels (gray bars) and pixels with both CD45
and p67phox expressed as a percent of total p67phox are shown in
open bars. Results for unstimulated cells are presented on the left for
comparison with PMA stimulated cells on the right. Prdx6 associated
with CD45 was 28% and increased to 49% after PMA stimulation.
p67phox associated with CD45 went from 28% in unstimulated cells
to 56% with PMA treatment. The difference between values for restingFig. 3. Translocation of Prdx6 in human neutrophils detected by confocal microscopy. Isolat
poly L-lysine-coated coverslips, incubated with a rabbit IgG antibody against CD45 and C
p67phox and Cy5 labeled anti-p29 Prdx6. Fluorescent probes were detected with a digital ﬂ
(A) Unstimulated cells demonstrate diffuse cytosolic localization of p67phox (blue) and Prd
ciated with membrane (merged and white, RGB colocalization panels). (B) PMA-stimulated
white, RGB colocalization panels). (C) Pixels with Prdx6 and CD45 were expressed as a perc
as a percent of total p67phox pixels (open bars). Unstimulated cells are represented in left p
51 stimulated cells. The amounts of both Prdx6 and p67phox associated with CD45 increase
ﬂuorescence were expressed as a percentage of the total Prdx6 pixels (gray bars) and as a pe
unstimulated and 51 stimulated cells studied. The amount of both Prdx6 and p67phox asso
(E) Prdx6 pixels colocalizing with p67phox pixels were expressed as a percentage of total Prd
expressed as a percentage of total p67phox pixels in the cell (open bars). The same cells w
unstimulated and stimulated cells.and stimulated cells for each protein was signiﬁcant (pb0.001, un-
paired t-test). This data conﬁrmed increased association of Prdx6 and
p67phox after stimulation with PMA.
In an additional analysis, pixels containing all three ﬂuors were
expressed as percent of total p67phox pixels in the cell to measure
p67phox colocalization with membrane. A similar evaluation for
Prdx6 pixels established colocalization for this protein in the plasma
membrane. As seen in Fig. 3D, p67phox and Prdx6 colocalization in
the plasma membrane increased when neutrophils were stimulated
from 23% to 49% (open bars) and 17% to 37% (gray bars) respectively.
This was signiﬁcant, pb0.005 by unpaired t-test. Fig. 3E shows the
amount of Prdx6 associated with p67phox as a percentage of total
Prdx6 (gray bars) or p67phox associated with Prdx6 as a percentage
of total p67phox (open bars). There was no difference between either
of these measurements in unstimulated or stimulated neutrophils.
In both unstimulated and stimulated neutrophils however, the per-
centage of Prdx6 associated with p67phox, as a percentage of total
Prdx6, was less than p67phox associated with Prdx6 as a percentage
of total p67phox (pb0.05, unpaired t-test). About 60% of Prdx6 was
associated with p67phox (gray bars), but more p67phox (75–80%)
was associated with Prdx6 (open bars) suggesting that Prdx6 is pre-
sent in excess relative to p67phox and may serve other functions.
These studies demonstrate cotranslocation of Prdx6 and p67phox to
the neutrophil plasma membrane after stimulation with PMA and
conﬁrm Western blot results.
3.3. Involvement of p67phox and p47phox in Prdx6 translocation
K+++ cells, cells without p67phox (K47/91) or p47phox (K67/91),
and non-tranduced K562 cells were treated with PMA (1 μg/ml) for
5 min, and plasma membranes isolated. Western blotting for Prdx6,
p47phox and p67phox was performed on the membranes. Fig. 4A
shows a representative Western blot for each cell type and protein,
and Fig. 4B summarizes quantitation of these proteins as a ratio be-
tween the amounts in stimulated and unstimulated membranes. Efﬁ-
cient translocation of all three proteins was documented in K+++
cells after PMA stimulation. The highest ratio for Prdx6 was observed
in these cells with a 3-fold increase in Prdx6 in the membrane fraction
(pb0.005, paired t-test). No signiﬁcant increase in the ratio above 1
was seen in cells deﬁcient in p67phox (K47/91) or p47phox (K67/91).
Increases in the ratio for p47phox or p67phox are demonstrated only
in K+++ cells (pb0.005, paired t-test). A small amount of Prdx6 is
seen in unstimulated plasma membranes (Fig. 4A), particularly those
from K47/91 cells, suggesting that by binding Prdx6, p67phox may
play a role in restricting the distribution of Prdx6 to the cytosol until ac-
tivation of NADPH oxidase occurs. A less robust translocation of Prdx6
was associated with PMA stimulation of K562 cells lacking p47phox
and p67phox (Fig. 4A, B). However, this is signiﬁcantly less than that
seen in the K+++ cells (pb0.05, paired t-test). Previous studies have
demonstrated the requirement of the interaction of p47phox with
p67phox and cotranslocation of both to form an active oxidase suggest-
ing that p47phox acts as an adaptor linking p67phox to the membrane
oxidase complex [16,17]. Our results demonstrate that both p47phoxed neutrophils, unstimulated or stimulated with PMA (1 μg/ml for 5 min) were ﬁxed to
y3 labeled anti-rabbit IgG, then permeabilized and incubated with FITC-labeled anti-
uorescence microscope at 90×. Images generated were analyzed with IMAJIN_COLOC.
x6 (red) that was mainly separate from CD45 (green) with only a small amount asso-
cells demonstrate increased colocalization of p67phox, Prdx6 and CD45 (merged and
ent of total Prdx6 pixels (gray bars) and those with p67phox and CD45 were expressed
air and PMA stimulated on right. Results are mean±SEM for 28 unstimulated cells and
d with stimulation, pb0.001, unpaired t-test. (D) Pixels with Prdx6, p67phox and CD45
rcentage of total p67phox pixels (open bars) in that cell. Results are mean±SEM for 28
ciated with membrane increased after stimulation with PMA, pb0.005, unpaired t-test.
x6 pixels in the cell (gray bars) and p67phox pixels colocalizing with Prdx6 pixels were
ere analyzed as in C. Most Prdx6 and p67phox were colocalized to the same extent in
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Fig. 4. Western blot analysis for Prdx6, p47phox and p67phox in plasma membrane
from unstimulated and PMA-stimulated K562, K+++, K47/91 and K67/91 transduced
cells. (A) Representative experiment detecting proteins in plasma membranes from
unstimulated (−) or PMA-stimulated (+) cells as noted in Materials and methods.
(B) Quantitation of Prdx6 (dark gray bars), p47phox (light gray bars) and p67phox
(white bars) in plasma membranes from unstimulated and PMA-stimulated cells.
Numbers represent ratios of stimulated to unstimulated membranes analyzed by ImageJ
and results are mean±SEM. Number of experiments was 13 for Prdx6 and 4 for
p47phox and p67phox.
Fig. 5. Effect of rh-Prdx6 on oxidase activity in the SDS-activated cell-free system. Pro-
duction of O2− was measured as described in Materials and methods: recombinant
p47phox and p67phox (100 nM) and constitutively active Rac (32 nM) were incubated
for 10 min in the presence or absence of rh-Prdx6. Plasma membrane (1 μg) and SDS
were added and incubated for 3 min. The reaction was initiated with the addition of
NADPH. (A) O2− production (nmol/min) in the presence of 0, 0.27, 0.55, 1.10 and
2.20 μM rh-Prdx6 and varying concentrations of NADPH (20–200 μM). rh-Prdx6 en-
hanced the rate at each concentration of NADPH but did not alter the concentration
of NADPH for half maximal rate. Symbols and bars are mean±SEM of 4 separate exper-
iments. (B) Concentration dependent effects of Prdx6 in the cell-free system. The in-
crease (Δ) in rate of O2− production with the addition of rh-Prdx6 compared to its
absence plotted against the concentration of Prdx6 in the presence of 200 μM
NADPH. The plot represents four separate experiments; symbols and bars are mean±
SEM. rh-Prdx6 increase O2− production in a concentration-dependent manner exhibiting
a hyperbolic curve.
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membrane. The possibility of independent associations of Prdx6 with
the membrane in the absence of phox proteins, perhaps through inter-
actions with its lipid substrates, is raised by these studies.
3.4. Effects of rh-p29 Prdx6 on the kinetics of oxidase activity in the SDS
activated cell-free system
Previous studies demonstrated that rh-Prdx6 enhanced produc-
tion of O2− and oxygen consumption by a cell-free system of oxidase
activity using neutrophil plasma membrane and recombinant cyto-
solic phox proteins [12]. We complemented our current results with
intact cells by additional studies in the cell-free system to determine
the characteristics and speciﬁcity of the enhancement by Prdx6. First,
with several different concentrations of Prdx6 added to the reaction
mixture, the rate of O2− production was determined at various con-
centrations of NADPH. Results from these studies are shown in
Fig. 5A. All the rh-Prdx6 concentrations increased the rate of O2− gen-
eration but did not change the concentration of NADPH at half maximal
rate. Kinetic parameters of the oxidase were calculated with these data
and the results are presented in Table 1. Additions of Prdx6 at concen-
trations up to 2.2 μM had no effect on the Km for NADPH. However,
the Vmax was signiﬁcantly increased at concentrations above 0.55 μM
Prdx6.
In the second set of experiments, assays were completed using a
wider range of rh-Prdx6 concentrations and 200 μM NADPH. The dif-
ference in rate of O2− production between the system with and with-
out the recombinant protein was calculated for each concentration of
rh-Prdx6 added. The results are shown in Fig. 5B. rh-Prdx6 produces a
saturable, concentration-dependent increase in oxidase activity. Thus,
enhanced production of O2− in the cell-free system appears to be due
to a speciﬁc effect on the oxidase rather than increasing O2− production
by another means such as chemical ROS generation.
The ability of Prdx6 to increase the Vmax of the oxidase suggests
that this protein increases the catalytic efﬁciency of the active oxidasecomplex and/or increases the total amounts of oxidase proteins
retained within an active complex. To further explore these possibil-
ities, we used si1 to suppress Prdx6 in K+++ cells and Nsi as a control
as previously described (Section 2.7). After 48 h, cells were incubated
with PMA (1 μg/ml) or buffer for 5 min, disrupted and plasma mem-
branes collected on sucrose gradients after-centrifugation. Membrane
proteins were separated on SDS-PAGE and oxidase proteins p67phox,
p47phox, and gp91phox identiﬁed and quantiﬁed as previously de-
scribed (Section 2.10). The ratio of the speciﬁc proteins in stimulated
membranes compared to resting membranes was calculated for cells
treated with si and Nsi. Results for two separate preparations of cells
are shown in Fig. 6. Knockdown of Prdx6 was achieved as previously
noted (data not shown). In K+++ cells with Prdx6 not suppressed,
both p47phox and p67phox demonstrated higher stimulated/
unstimulated ratios (pb0.05 and pb0.001, paired t-test) compared
to results for cells in which Prdx6 was reduced by siRNA. gp91phox
remained unchanged in all experiments (data not shown). This data
suggests that the presence of Prdx6 results in increased amounts of
cytosolic phox proteins retained in the active oxidase complex.
Fig. 7. Effects of Prdx6 mutations on cell-free oxidase activity. (A) SDS-PAGE (Coomas-
sie blue staining, top) and Western blot analysis for rh-Prdx6 (WT), C47S, and S32A
proteins (probed with polyclonal antibody to Prdx6), bottom). (B) Activity of rh-wt,
C47S, and S32A in the SDS-activated cell-free assay of oxidase activity. Proteins were
added at 1 μM. O2− production was measured as described in “Materials and methods”
expressed as fold increase over the system without Prdx6 protein. Results are mean±
SEM for 5 experiments for rh-wt and 6 each for C47S and S32A.
Table 1
Kinetic parameters for NADPH at various concentrations of Prdx6 in the reaction
mixture.






a Numbers represent mean±SEM of 4 separate experiments at each concentration.
b Signiﬁcantly different from no rh-p29 Prdx6 added pb0.05 by unpaired t-test.
313D.R. Ambruso et al. / Biochimica et Biophysica Acta 1823 (2012) 306–3153.5. Mutation of Prdx6 and activity in the SDS, cell-free system of oxidase
activity
Cysteine 47 of Prdx6 is critical for the Prdx activity of this protein
and serine 32 is required for the PLA2 activity [19,21,34]. Mutant
Prdx6 proteins (C47S and S32A) were expressed and puriﬁed from
baculovirus-infected sf-9 cells, as described in Materials and methods.
Mutant recombinant Prdx6 proteins, C47S and S32A, appeared identical
to rh-Prdx6 (WT) on SDS-PAGE and Western blotting (Fig. 7A). These
three proteins were individually added to the cell-free system of oxi-
dase activity at a concentration of 1 μM, and the effect onO2− production
evaluated. WT, C47S, and S32A proteins all enhanced the generation of
O2− by the cell-free system between 2 and 2.5 fold and no difference be-
tween any of the proteins was noted (Fig. 7B). These studies imply that
neither the Prdx nor PLA2 activities of Prdx6 is responsible for
increasing O2− production in the cell-free system and the observed en-
hancement is related to a distinct effect on NADPH oxidase activity.
4. Discussion
Our studies were initiated with the observation that Prdx6 in neu-
trophils is found in association with the NADPH oxidase component,
p67phox [12]. The interaction was deﬁned by immunoprecipitation
and conﬁrmed with yeast-two hybrid studies. A cDNA for Prdx6 was
isolated from neutrophils and the recombinant protein generated
from this cDNA was a 1-Cys peroxiredoxin by sequence homology
and H2O2 reducing activity and exhibited PLA2 activity with an opti-
mal activity at low pH and no requirement for calcium, as others
have shown [12,27–29]. Finally, in a cell-free system of NADPH oxi-
dase activity, Prdx6 enhanced both O2 consumption and O2− produc-
tion [12].
The current investigations extend our understanding of the physio-
logic relevance of Prdx6 in oxidase activity in intact cells. While mature
neutrophils are difﬁcult to maintain in culture or use in transfection
studies for speciﬁc proteins, transduced cells reconstitutedwith oxidase
components have been employed to explore the biochemistry of theFig. 6. Ratio of phox components in membranes from PMA stimulated compared to
unstimulated K562 oxidase competent cells with and without suppression of Prdx6.
Closed bars represent results from Nsi treated control cells and open bars represent
si treated cells with suppression of Prdx6. Results are shown for p47phox and
p67phox. Bars and brackets show mean±SEM for 9 experiments with two separate
preparations. Ratio for p47phox is decreased in si suppressed cells, pb0.05, and for
p67phox, pb0.001, paired t-test.NADPH oxidase system [16,17,27,33]. We combined the use of phox-
competent K562 (K+++) cells stably transfected with the fMLP recep-
tor along with siRNA targeting Prdx6 to suppress this protein and ex-
plore its effects on NADPH oxidase activity. Three siRNA molecules
speciﬁcally silencing expression of Prdx6 were compared with a non-
silencing siRNA probe. The silencing molecules decreased the detect-
able levels of Prdx6 to 23–40% of the Nsi control. No signiﬁcant effect
was demonstrated on any of the phox components or actin. Production
of O2− in response to fMLP or PMA stimulation was decreased in cells
with reduced Prdx6 compared to non-silenced control cells. Results
with K562 cells are consistent with our previous data from the cell-fee
system [12] which indicated that Prdx6 enhances the activity of
NADPH oxidase.
In resting neutrophils, the oxidase complex lies dormant with
some components (p40phox, p47phox, p67phox and Rac2) residing
in the cytosol and the cytochrome b558 (gp91phox and p22phox) con-
tained in the plasma membrane or membrane of the speciﬁc granules
[8–10]. With stimulation, the cytosolic components translocate to
speciﬁc granules or to the plasma membrane, assembling the active
oxidase complex [6,8–10,35]. In this study, two techniques, Western
blotting plasma membrane after subcellular fractionation and analysis
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assembled with the p47phox and p67phox components in the plasma
membrane after stimulation of oxidase activity. Immunoprecipitation
studies with plasma membrane from PMA stimulated neutrophils fur-
ther supports evidence of interaction between p67phox and Prdx6. In
the oxidase-reconstituted K562 cell model, optimal Prdx6 translocation
required the presence of oxidase components, speciﬁcally the presence
of both p47phox and p67phox. This is consistent with binding of Prdx6
to p67phox and previous studies demonstrating the requirement of
p47phox for p67phox assembly into the activeNADPH oxidase complex
[12,16,17]. Translocation of Prdx6 further expands the relationship of
these proteins in assembly and activation of NADPH oxidase. The asso-
ciation of a small amount of Prdx6with plasmamembrane of PMA stim-
ulated K562 cells without p67phox and p47phox as well as confocal
studies in neutrophils demonstrating that some Prdx6 is not associated
with p67phox opens the possibilities of other roles of this protein in
myeloid function involving ROS scavenging or phospholipase activity.
In an additional series of experiments, recombinant Prdx6had speciﬁc
effects in supporting higher levels of oxidase activity in vitro. Although
it was not required for baseline activity of the cell-free system, which
requires soluble amphiphiles (SDS or arachidonate) in place of the nor-
mal physiological signaling events that direct assembly ofNADPHoxidase
components inwhole cells [36–40], Prdx6was found to enhance the rate
of O2− production in a concentration-dependent manner. In kinetic stud-
ies of NADPH oxidase activity, Prdx6 did not change the Km for NADPH,
but did increase the Vmax, exhibiting a hyperbolic relationship that was
consistent with saturable binding to the oxidase. The data suggest
Prdx6 enhances the rate at which the NADPH oxidase generates O2− ,
either by enhancing the ﬂow of electrons through the complex or by sta-
bilizing the oxidase complex or active conformations of its components.
Studies demonstrating increased ratios of p47phox and p67phox in
membranes of stimulated cellswhose Prdx6 is not suppressed in compar-
ison to low ratios in cells with Prdx6 knocked down suggests that this
protein not only enhances activity throughout activation (Fig. 1D) but
also supports retention of the components in the active complex.
In the cell-free system, production of O2− was enhanced to the
same extent by rh-Prdx6 and mutant proteins with deﬁcient Prdx or
PLA2 activity [12,19,21,34]. This implies that Prdx6 may have a dis-
tinct function with the oxidase in the cell-free system separate from
its Prdx or PLA2 activity. However, the cell-free system circumvents
signaling and modiﬁcations that may be critical to protein function
in intact cells. Thus, Prdx, PLA2 activity, or even phosphorylation
may be important for the intracellular function of Prdx6 in oxidase ac-
tivity, whereas these activities are not required for in vitro oxidase
reconstitution in the cell-free system.
Peroxiredoxins are a new class of proteins that catalytically de-
grade H2O2 [11]. Several classes exist based on the number of active
cysteines and their activity. Prdx6 falls into a class of 1-Cys peroxire-
doxins with one active cysteine and exhibits an additional activity,
that of a PLA2 [11,19,21,34]. Like other peroxiredoxins, Prdx6 is
thought to protect against excess ROS generation, particularly H2O2
and peroxidized lipid, and is known to modulate the strength of
redox-based cellular signaling [11], but little is known about its spe-
ciﬁc function within eukaryotic cells. Prdx6 has been identiﬁed in
lung tissue and provided protection against ROS toxicity in the lung
[41–43]. Recently, Prdx6 has been implicated in angiotensin II induced
activation of pulmonary microvascular endothelial cells and alveolar
macrophages [44]. This study demonstrated that MAPK activation
leads to phosphorylation of Prdx6, assembly to the plasma membrane
facilitating assembly and activation of the Nox2 complex. While Nox2
is less robust in endothelial cells, this data supports a similar role for
Prdx6 in the NADPH oxidase in neutrophils. The effect of Prdx6 on ac-
tivity of the oxidase suggests a possible physiologic role inmicrobicidal
activity. Preliminary studies in PLB-985 promyelocytic cell line in
which a stable knockdown of Prdx6 (30% of vector control) in DMSO
matured cells resulted in a decrease in O2− production by 62%. Killingof S. aureus at 30 min was 67% in non-knockdown cells and 29% in
knockdown cells with no difference in ingestion rates [45]. Investiga-
tions are underway to further evaluate microbicidal activities in mye-
loid cells with deﬁcient Prdx6.
The PLA2 activity of this protein in vitro does not require Ca++
and is optimal at low pH, which may limit the relevance of its activity
in the neutrophil cytoplasm. However, NADPH oxidase generates cy-
tosolic protons as it consumes cytosolic NADPH and would thereby
support higher PLA2 activity of Prdx6 within the oxidase complex.
Recent studies also demonstrated that phosphorylation of Prdx6
changes the pH optimum for its PLA2 activity to a more neutral
range [44,46]. Phosphorylation may be affected by MAP kinases
which are important in neutrophil function including NADPH oxidase
activation [47,48]. Furthermore, oxidation of cysteine at position 47
appears to enhance the PLA2 activity of Prdx6 [42]. Thus, complex
changes in Prdx6may alter its PLA2 activity during oxidase activation,
thereby providing a positive feedback mechanism between oxidase
and phospholipase activities with particular relevance to myeloid
cell function. These intriguing possibilities for the relationship of
these changes in Prdx6 and its role as a regulator of oxidase activity
in whole cells require further study. Interestingly, another phospholi-
pase (cPLA2) that assembles within the active, membrane-bound
NADPH oxidase complex, through interactions with p47phox, was also
proposed to serve as a positive regulator of oxidase function [49,50].
5. Conclusion
Our investigations with neutrophils, the cell-free system of
NADPH oxidase activity and reconstituted K562 cells expressing
NADPH oxidase activity demonstrate that Prdx6 translocates to the
plasma membrane requiring other cytosolic phox components, en-
hances the activity of the oxidase, and supports retention of phox
proteins in the active complex. The enhancement effect is saturable
and speciﬁc; and, although not essential for baseline oxidase activity,
appears to play a role in optimal NADPH oxidase activity. This protein
has the potential for dramatic effects on myeloid function. Additional
work is needed to explore the mechanisms for these effects on
NADPH oxidase and its relationship to biochemical activities of Prdx6.
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